Neostigmine
- Product NDC
- 43598-528
- 11-digit product format
- 435980528
- Labeler code
- 43598
- Product ID
- 43598-528_649d8760-81df-13da-6556-14a0fdbc8b02
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Neostigmine
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Dr.Reddy's Laboratories Inc
- Application
- ANDA209135
- Marketing category
- ANDA
- Marketing start
- 2018-09-04
- Substance
- NEOSTIGMINE METHYLSULFATE
- Active strength
- .5 mg/mL
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Neostigmine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| NEOSTIGMINE METHYLSULFATE | .5 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 98IMH7M386 |
| Rxcui | 311935, 311936 |
DailyMed Product Concepts#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43598-528 | NEOSTIGMINE INJECTION [DR.REDDY'S LABORATORIES INC] | 4 | Current NDC, Legacy NDC | 20210303_81243f47-bd25-bd02-518a-087badcca755.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43598-528-11 | 43598052811 | 1 VIAL, MULTI-DOSE in 1 CARTON (43598-528-11) / 10 mL in 1 VIAL, MULTI-DOSE | 2018-09-04 | 0000-00-00 | No | No | Current |
| 43598-528-36 | 43598052836 | 10 VIAL, MULTI-DOSE in 1 CARTON (43598-528-36) / 10 mL in 1 VIAL, MULTI-DOSE | 2018-09-04 | 0000-00-00 | No | No | Current |